Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus.

Rutter, Megan, Lanyon, Peter C, Sandhu, Ravinder, Batten, Rebecca L, Garner, Rozeena, Little, Jayne, Narayan, Nehal, Sharp, Charlotte A, Bruce, Ian N, Erb, Nicola, Griffiths, Bridget, Guest, Hannah, Macphie, Elizabeth, Packham, Jon, Hiley, Chris, Obrenovic, Karen, Rivett, Ali, Gordon, Caroline and Pearce, Fiona A (2021) Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus. Rheumatology (Oxford, England), 60 (3). pp. 1474-1479. ISSN 1462-0332. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

[img]
Preview
Text (PDF file format)
keaa620.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial 4.0.

Download (204kB) | Preview
Official URL: http://rheumatology.oxfordjournals.org/

Abstract

OBJECTIVES

We aimed to estimate what proportion of people with SLE attending UK rheumatology clinics would be categorized as being at high risk from coronavirus disease 2019 (COVID-19) and therefore asked to shield, and explore what implications this has for rheumatology clinical practice.

METHODS

We used data from the British Society for Rheumatology multicentre audit of SLE, which included a large, representative cross-sectional sample of patients attending UK Rheumatology clinics with SLE. We calculated who would receive shielding advice using the British Society for Rheumatology's risk stratification guidance and accompanying scoring grid, and assessed whether ethnicity and history of nephritis were over-represented in the shielding group.

RESULTS

The audit included 1003 patients from 51 centres across all 4 nations of the UK. Overall 344 (34.3%) patients had a shielding score ≥3 and would have been advised to shield. People with previous or current LN were 2.6 (1.9-3.4) times more likely to be in the shielding group than people with no previous LN (P < 0.001). Ethnicity was not evenly distributed between the groups (chi-squared P < 0.001). Compared with White people, people of Black ethnicity were 1.9 (1.3-2.8) and Asian 1.9 (1.3-2.7) times more likely to be in the shielding group. Increased risk persisted after controlling for LN.

CONCLUSION

Our study demonstrates the large number of people with SLE who are likely to be shielding. Implications for clinical practice include considering communication across language and cultural differences, and ways to conduct renal assessment including urinalysis, during telephone and video consultations for patients who are shielding.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: W Public health. Health statistics. Occupational health. Health education
WC Communicabable diseases
WE Musculoskeletal. Orthopaedics
WJ Urogenital system. Urology
Divisions: Ambulatory Care > Rheumatology
Related URLs:
Depositing User: Jamie Edgar
Date Deposited: 18 Mar 2021 10:12
Last Modified: 18 Mar 2021 10:12
URI: http://www.repository.uhblibrary.co.uk/id/eprint/4102

Actions (login required)

View Item View Item